Progress Biotech supplies high-docosahexaenoic acid (DHA) oil and encapsulated oil that can be used as a starting material in the production of active pharmaceutical ingredients (API).

The oils in Progress Biotech’s portfolio start at 40% DHA and can be increased to concentrations as high as 75%.

Featuring high levels of omega 3 fatty acid, the oil’s high purity makes it suitable for pharmaceutical applications. The company collaborates closely with clients to develop customised applications to meet demand.

Progress Biotech's high-docosahexaenoic acid (DHA) oil is produced from schizochytrium algae.
The oil is available as a 10% DHA powder that can be mixed with other ingredients.
Progress Biotech’s portfolio features around 40%-50% DHA content.
The company's oil contains high levels of omega 3 fatty acid, which is beneficial for eye health.
Progress Biotech's experienced team of scientists ensure oil purity is maintained.
The company's algal oils with 75% DHA concentrate are suitable for medical and pharmaceutical applications.
Progress Biotech's products meet the requirements of the International Standards Organisation (ISO), European Food Safety Authority (EFSA) and the US Food and Drug Administration (FDA).
Progress Biotech provides winterisation of oil to increase DHA concentrations.

Algal oils with 75% DHA concentrate for medical applications

Progress Biotech provides some of the highest available DHA concentrations from algae on the market, reaching 75% DHA content. This is suitable for medical and pharmaceutical applications where a small volume of oil needs to be combined with a high dosage of DHA.

The company supplies this high concentrate in both the ethyl ester (EE) and triglyceride (TG) forms.

A proprietary strain of the schizochytrium algae is used for production using fermentation techniques. The oil is refined and concentrated in Europe with state-of-the-art refinery techniques. Every step in the production is analysed by certified laboratories worldwide.

Progress Biotech keeps its products in a certified cold store before being shipped directly to clients.

Contaminant and allergen-free oil for APIs

Progress Biotech’s scientists work to continuously improve the company’s manufacturing systems for its DHA algae oil. Its certified quality management system (CMS) guarantees high standards and specifications, enabling the firm to guarantee safety and full traceability.

This meets the requirements of the International Standards Organisation (ISO) 22000 certification, European Food Safety Authority (EFSA) novel food approval and US Food and Drug Administration (FDA) registration.

The company’s algae oil is mechanically extracted without the use of solvents. This technique guarantees no solvent traces in the oil.

This certified-vegan DHA oil is also free from dioxins, polycyclic aromatic hydrocarbons (PAH) or polychlorinated biphenyls (PCB), which are present in traditional sources of omega 3 fatty acid.

Progress Biotech’s production methods ensure that its DHA oil is allergen-free.

Winterised and encapsulated DHA oil for pharmaceutical applications

Progress Biotech’s portfolio features high-DHA content of 40%, 50% or 75%. For applications that require a clearer and purer oil, the company can offer winterisation.

In addition, the oil can be processed as a highly stable, free-flowing 10% DHA powder that can be mixed with other ingredients.

About Progress Biotech

Founded in 2011, Progress Biotech supplies flavourless, odourless and clear high-DHA algal oils worldwide.

The company is supported by an experienced team of scientists covering a wide field of expertise. Its experts have more than 100 years of combined experience in biochemistry, biotechnology, medicine and animal nutrition, with a strong focus on research and development (R&D).